Dr. Hans Rensland, Vice President Regulatory Affairs at Nitec, was for the last four years the Director of Regulatory Affairs at Biologische Heilmittel Heel GmbH. Previous to this, he has held senior positions in Regulatory Affairs in a variety of international acting companies including Merck KGaA, Knoll AG, and Intersan GmbH. Dr. Rensland completed his PhD in oncology at the Max Planck Institute for Medical Research in Heidelberg in 1992.
Dr. Rainer Rogasch will work as Vice President Technical Operations & Development and was previously General Manager and Technical Director at Madaus GmbH. Before, Dr. Rogasch was Head of Production and Development at alphamed Pharbil/PenCef GmbH. Dr. Rogasch also worked in Pharmacy Management after graduating with a PhD in pharmaceutical technology as Pharmacist from the Philipps-University Marburg/Lahn, Germany.
Dr Markus Vogt, Vice President of Quality and Compliance, was formerly Head of Technical Development at Nitec Pharma. Previous to this, Dr Vogt held a variety of positions in pharmaceutical development at Merck KGaA. He received his PhD in pharmaceutical technology from the University of Frankfurt during this period. He originally studied pharmacy at Johannes Gutenberg-Universitat, Mainz, and completed the State Exams in pharmacy in 2001.
James Audibert (based in New Jersey/US), Vice President Commercial
Optimization, has over 30 years of experience in the pharmaceutical
industry. Most of his career was spent with Key Pharmaceuticals and
Schering Plough (SP) where he was involved in US sales and marketing,
managed care, global marketing, and research. From 1995 to 2000, he was
responsible for SP's Global Marketing Cardiovascular Business Unit, and
then moved to the Sc
|SOURCE Nitec Pharma AG|
Copyright©2007 PR Newswire.
All rights reserved